TELA Bio | 10-Q: Q2 2024 Earnings Report
TELA Bio | 8-K: TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Officer Firestone Gregory A.
TELA Bio | SCHEDULE 13G: Others
TELA Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(5.4%)
TELA Bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(9.9%),OrbiMed Capital GP IV LLC(9.9%)
TELA Bio | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
TELA Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
TELA Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-F(0%),Mathew P. Arens(0%)
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director O'Brien Federica F.
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director Burgess Vincent J
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director COLLERAN LISA N
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director Azarbarzin Kurt
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director EVANS DOUGLAS G
TELA Bio | 3: Initial statement of beneficial ownership of securities-Director Blizard Jeffrey
TELA Bio | 4: Statement of changes in beneficial ownership of securities-Director Blizard Jeffrey
TELA Bio | 8-K: Current report
TELA Bio | 8-K: Current report
TELA Bio | 10-Q: Q1 2024 Earnings Report
TELA Bio | 8-K: TELA Bio Reports First Quarter 2024 Financial Results
No Data